A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression

Integrated analysis of multimodal single-cell data

Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508 · see citing works

Comprehensive Integration of Single-Cell Data

Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453 · see citing works

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Jiang, P., Gu, S., Pan, D., Fu, J., Sahu, A., Hu, X., Li, Z., Traugh, N., Bu, X., Li, B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0136-1 · Cited by 5,179 · see citing works

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,285 · see citing works

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092 · see citing works

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · see citing works

Tolerogenic Dendritic Cells

Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,124 · see citing works

Dendritic cells in cancer immunology and immunotherapy

Wculek, S. K., Cueto, F. J., Mujal, A. M., Melero, I., Krummel, M. F., & Sancho, D. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0210-z · Cited by 2,594 · see citing works

Ido expression by dendritic cells: tolerance and tryptophan catabolism

Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341 · see citing works

CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing

Labun, K., Montague, T. G., Krause, M., Cleuren, Y. N. T., Tjeldnes, H., & Valen, E. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz365 · Cited by 2,009 · see citing works

Hypoxia, HIF1 and glucose metabolism in the solid tumour

Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707 · see citing works

Immunometabolism governs dendritic cell and macrophage function

O'Neill, L., & Pearce, E. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151570 · Cited by 1,641 · see citing works

Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma

Zhang, Q., He, Y., Luo, N., Patel, S. J., Han, Y., Gao, R., Modak, M., Carotta, S., Haslinger, C., Kind, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.003 · Cited by 1,624 · see citing works

An Interaction between Kynurenine and the Aryl Hydrocarbon Receptor Can Generate Regulatory T Cells

Mezrich, J. D., Fechner, J. H., Zhang, X., Johnson, B. P., Burlingham, W. J., & Bradfield, C. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903670 · Cited by 1,617 · see citing works

A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells

Cheng, S., Li, Z., Gao, R., Xing, B., Gao, Y., Yang, Y., Qin, S., Zhang, L., Ouyang, H., Du, P., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.010 · Cited by 1,601 · see citing works

Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer

Zhang, L., Li, Z., Skrzypczynska, K. M., Fang, Q., Zhang, W., O’Brien, S. A., He, Y., Wang, L., Zhang, Q., Kim, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.048 · Cited by 1,575 · see citing works

Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy

Spranger, S., Dai, D., Horton, B., & Gajewski, T. F. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.003 · Cited by 1,441 · cited 1× · see citing works

Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes

Horton, J. D., Shah, N. A., Warrington, J. A., Anderson, N. N., Park, S. W., Brown, M. S., & Goldstein, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1534923100 · Cited by 1,427 · see citing works

BrafV600E cooperates with Pten loss to induce metastatic melanoma

Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189 · see citing works

Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition

Salmon, H., Idoyaga, J., Rahman, A. H., Leboeuf, M., Remark, R., Jordan, S., Casanova-Acebes, M., Khudoynazarova, M. N., Agudo, J., Tung, N., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.012 · Cited by 1,187 · see citing works

Lactate: A Metabolic Key Player in Cancer

Hirschhaeuser, F., Sattler, U. G. A., & Mueller‐Klieser, W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1457 · Cited by 1,093 · see citing works

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,074 · see citing works

Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase

Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R. E., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028 · see citing works

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Garris, C. S., Arlauckas, S. P., Kohler, R. H., Trefny, M. P., Garren, S., Piot, C., Engblom, C., Pfirschke, C., Siwicki, M., Gungabeesoon, J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.024 · Cited by 966 · see citing works

A conserved dendritic-cell regulatory program limits antitumour immunity

Maier, B. B., Leader, A. M., Chen, S. T., Tung, N., Chang, C., Bérichel, J. L., Chudnovskiy, A., Maskey, S., Walker, L. A., Finnigan, J. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2134-y · Cited by 950 · see citing works

ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis

Cubillos-Ruiz, J. R., Silberman, P. C., Rutkowski, M. R., Chopra, S., Perales-Puchalt, A., Song, M., Zhang, S., Bettigole, S. E., Gupta, D., Holcomb, K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.025 · Cited by 933 · see citing works

Dendritic Cells and Cancer Immunity

Gardner, A., & Ruffell, B. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.09.006 · Cited by 896 · see citing works

Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase

DuPage, M. J. P., Dooley, A. L., & Jacks, T. (2009) · Nature Protocols · doi:10.1038/nprot.2009.95 · Cited by 862 · see citing works

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes

Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21583 · Cited by 852 · see citing works

A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling

Qian, J., Olbrecht, S., Boeckx, B., Vos, H., Laoui, D., Etlioglu, E., Wauters, E., Pomella, V., Verbandt, S., Busschaert, P., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0355-0 · Cited by 818 · see citing works

Metabolic Induction of Trained Immunity through the Mevalonate Pathway

Bekkering, S., Arts, R. J. W., Novakovic, B., Kourtzelis, I., van der Heijden, C. D. C. C., Li, Y., Popa, C. D., ter Horst, R., van Tuijl, J., Netea-Maier, R. T., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.025 · Cited by 794 · see citing works

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

Sharma, M. D., Baban, B., Chandler, P., Hou, D., Singh, N., Yagita∥, H., Azuma, M., Blazar, B. R., Mellor, A. L., & Munn, D. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31911 · Cited by 791 · see citing works

Deciphering the transcriptional network of the dendritic cell lineage

Miller, J. C., Brown, B. D., Shay, T., Gautier, E. L., Jojic, V., Cohain, A. T., Pandey, G. S., Leboeuf, M., Elpek, K. G., Helft, J., et al. (2012) · Nature Immunology · doi:10.1038/ni.2370 · Cited by 779 · see citing works

Lipid accumulation and dendritic cell dysfunction in cancer

Herber, D. L., Cao, W., Nefedova, Y., Novitskiy, S. V., Nagaraj, S., Tyurin, V. A., Corzo, A., Cho, H.-I., Celis, E., Lenox, B. C., et al. (2010) · Nature Medicine · doi:10.1038/nm.2172 · Cited by 741 · see citing works

The interplay between cell signalling and the mevalonate pathway in cancer

Mullen, P., Yu, R., Longo, J., Archer, M. C., & Penn, L. Z. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.76 · Cited by 699 · see citing works

SCENITH: A Flow Cytometry-Based Method to Functionally Profile Energy Metabolism with Single-Cell Resolution

Argüello, R. J., Combes, A. J., Char, R., Gigan, J. P., Baaziz, A. I., Bousiquot, E., Camosseto, V., Samad, B., Tsui, J. L., Yan, P., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.007 · Cited by 563 · see citing works

Metabolic heterogeneity confers differences in melanoma metastatic potential

Tasdogan, A., Faubert, B., Ramesh, V., Ubellacker, J. M., Shen, B., Solmonson, A., Murphy, M. M., Gu, Z., Gu, W., Martin, M., et al. (2020) · Nature · doi:10.1038/s41586-019-1847-2 · Cited by 509 · see citing works

Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer

Liu, X., Bao, X., Hu, M., Chang, H., Jiao, M., Cheng, J., Xie, L., Huang, Q., Li, F., & Li, C.-Y. (2020) · Nature · doi:10.1038/s41586-020-2911-7 · Cited by 490 · cited 3× · see citing works

Dendritic cell metabolism

Pearce, E. J., & Everts, B. (2014) · Nature reviews. Immunology · doi:10.1038/nri3771 · Cited by 482 · see citing works

PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer

Oh, S. A., Wu, D.-C., Cheung, J., Navarro, A., Xiong, H., Cubas, R. A., Tótpál, K., Chiu, H. H., Wu, Y., Comps‐Agrar, L., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0075-x · Cited by 463 · see citing works

Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy

Mayoux, M., Roller, A., Pulko, V., Sammicheli, S., Chen, S., Sum, E., Jost, C., Fransen, M. F., Buser, R. B., Kowanetz, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aav7431 · Cited by 394 · see citing works

Dendritic Cells in the Cancer Microenvironment

Ma, Y., Shurin, G. V., Peiyuan, Z., & Shurin, M. R. (2013) · Journal of Cancer · doi:10.7150/jca.5046 · Cited by 362 · see citing works

In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis

Roper, J., Tammela, T., Cetinbas, N. M., Akkad, A., Roghanian, A., Rickelt, S., Almeqdadi, M., Wu, K., Oberli, M. A., Rivera, F. J. S., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3836 · Cited by 345 · see citing works

Specialized role of migratory dendritic cells in peripheral tolerance induction

Idoyaga, J., Fiorese, C. J., Zbytnuik, L. D., Lubkin, A., Miller, J. C., MALISSEN, B., Mucida, D., Mérad, M., & Steinman, R. M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65260 · Cited by 305 · see citing works

Oxidized lipids block antigen cross-presentation by dendritic cells in cancer

Cao, W., Ramakrishnan, R., Tuyrin, V. A., Veglia, F., Condamine, T., Amoscato, A., Mohammadyani, D., Johnson, J. J., Min Zhang, L., Klein-Seetharaman, J., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302801 · Cited by 302 · see citing works

Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization

Zhao, F. L., Xiao, C., Evans, K. S., Theivanthiran, T., DeVito, N. C., Holtzhausen, A., Liu, J., Liu, X., Boczkowski, D., Nair, S. K., et al. (2018) · Immunity · doi:10.1016/j.immuni.2017.12.004 · Cited by 286 · see citing works

SREBP in signal transduction: cholesterol metabolism and beyond

Bengoechea-Alonso, M. T., & Ericsson, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.004 · Cited by 280 · see citing works

The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery

Xia, Y., Xie, Y., Yu, Z., Xiao, H., Jiang, G., Zhou, X., Yang, Y., Li, X., Zhao, M., Li, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.070 · Cited by 256 · see citing works

Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs

Cummings, R. J., Barbet, G., Bongers, G., Hartmann, B. M., Gettler, K., Muniz, L., Furtado, G. C., Cho, J., Lira, S. A., & Blander, J. M. (2016) · Nature · doi:10.1038/nature20138 · Cited by 228 · see citing works

Metabolic Control of Dendritic Cell Functions: Digesting Information

Wculek, S. K., Khouili, S. C., Priego, E., Heras‐Murillo, I., & Sancho, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00775 · Cited by 212 · see citing works

Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells

Kirkling, M. E., Cytlak, U., Lau, C. M., Lewis, K. L. T., Resteu, A., Khodadadi‐Jamayran, A., Siebel, C. W., Salmon, H., Mérad, M., Tsirigos, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.068 · Cited by 207 · see citing works

Extracellular Acidic pH Activates the Sterol Regulatory Element-Binding Protein 2 to Promote Tumor Progression

Kondo, A., Yamamoto, S., Nakaki, R., Shimamura, T., Hamakubo, T., Sakai, J., Kodama, T., Yoshida, T., Aburatani, H., & Osawa, T. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.006 · Cited by 205 · see citing works

Dendritic Cell Metabolism and Function in Tumors

Giovanelli, P., Sandoval, T. A., & Cubillos‐Ruiz, J. R. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.06.004 · Cited by 188 · see citing works

Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity

Broz, M. L., Binnewies, M., Boldajipour, B. A., Nelson, A. E., Pollack, J. L., Erle, D. J., Barczak, A. J., Rosenblum, M. D., DAUD, A. I., Barber, D. L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.11.010 · Cited by 182 · see citing works

Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy

Holtzhausen, A., Zhao, F. L., Evans, K. S., Tsutsui, M., Orabona, C., Tyler, D. S., & Hanks, B. A. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0167 · Cited by 179 · see citing works

PPARα Inhibition Overcomes Tumor-Derived Exosomal Lipid-Induced Dendritic Cell Dysfunction

Yin, X., Zeng, W., Wu, B., Wang, L., Wang, Z., Tian, H., Wang, L., Jiang, Y., Clay, R., Wei, X., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108278 · Cited by 175 · see citing works

Metabolic rewiring in melanoma

Ratnikov, B. I., Scott, D. A., Osterman, A. L., Smith, J. W., & Ronai, Z. A. (2016) · Oncogene · doi:10.1038/onc.2016.198 · Cited by 168 · see citing works

Transcriptional Networks Driving Dendritic Cell Differentiation and Function

Nutt, S. L., & Chopin, M. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.005 · Cited by 164 · see citing works

Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance

Newell, F., da Silva, I. P., Johansson, P. A., Menzies, A. M., Wilmott, J. S., Addala, V., Carlino, M. S., Rizos, H., Nones, K., Edwards, J. J., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.11.012 · Cited by 164 · see citing works

Homeostatic NF-κB Signaling in Steady-State Migratory Dendritic Cells Regulates Immune Homeostasis and Tolerance

Baratin, M., Foray, C., Demaria, O., Habbeddine, M., Pollet, É., Maurizio, J., Verthuy, C., Davanture, S., Azukizawa, H., Flores‐Langarica, A., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.003 · Cited by 163 · see citing works

Metabolism Is Central to Tolerogenic Dendritic Cell Function

Sim, W. J., Ahl, P. J., & Connolly, J. E. (2016) · Mediators of Inflammation · doi:10.1155/2016/2636701 · Cited by 111 · see citing works

LXR signaling controls homeostatic dendritic cell maturation

Bosteels, V., Maréchal, S., Nolf, C. D., Rennen, S., Maelfait, J., Tavernier, S. J., Vetters, J., Velde, E. V. D., Fayazpour, F., Deswarte, K., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.add3955 · Cited by 111 · see citing works

Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion

DeVito, N. C., Plebanek, M. P., Theivanthiran, B., & Hanks, B. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02876 · Cited by 103 · see citing works

Ceramide Inhibits Antigen Uptake and Presentation by Dendritic Cells

Sallusto, F., Nicolò, C., Maria, R. D., Corinti, S., & Testi, R. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2411 · Cited by 99 · see citing works

In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma

Dubrot, J., Lane-Reticker, S. K., Kessler, E., Ayer, A., Mishra, G., Wolfe, C. H., Zimmer, M. D., Du, P. P., Mahapatra, A., Ockerman, K. M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.001 · Cited by 87 · see citing works

The immunosuppressive enzyme IL4I1 promotes FoxP3 + regulatory T lymphocyte differentiation

Cousin, C., Aubatin, A., Gouvello, S. L., Apétoh, L., Castellano, F., & Molinier‐Frenkel, V. (2015) · European Journal of Immunology · doi:10.1002/eji.201445000 · Cited by 70 · see citing works

Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency

Politiek, F. A., & Waterham, H. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.724991 · Cited by 49 · see citing works

Hyper-IgD syndrome or mevalonate kinase deficiency

Stoffels, M., & Simon, A. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328349c3b1 · Cited by 48 · see citing works

Role of dendritic cell metabolic reprogramming in tumor immune evasion

Plebanek, M. P., Sturdivant, M. S., DeVito, N. C., & Hanks, B. A. (2020) · International Immunology · doi:10.1093/intimm/dxaa036 · Cited by 32 · see citing works

Lactate mediated metabolic crosstalk between cancer and immune cells and its therapeutic implications

Farsani, S. S. M., & Verma, V. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1175532 · Cited by 31 · see citing works

Statins and immunotherapy: Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC

Rossi, A., Filetti, M., Salimbeni, B. T., Piras, M., Rizzo, F., Giusti, R., & Marchetti, P. (2021) · Cancer Reports · doi:10.1002/cnr2.1368 · Cited by 26 · see citing works

Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors

Tenesaca, S., Vásquez, M., Álvarez, M., Otano, I., Fernández-Sendin, M., Trani, C. A. D., Ardaiz, N., Gomar, C., Bella, Á., Aranda, F., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001587 · Cited by 18 · see citing works

Mevalonate Kinase Deficiency: Disclosing the Role of Mevalonate Pathway Modulation in Inflammation

Marcuzzi, A., Crovella, S., Monasta, L., Brumatti, L. V., Gattorno, M., & Frenkel, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803530835 · Cited by 12 · see citing works

Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E

McManus, D., Novaira, H. J., Hamers, A. A. J., & Pillai, A. B. (2019) · Journal of Visualized Experiments · doi:10.3791/59821 · Cited by 11 · see citing works

Statin treatment improves response to anti-PD1 agents in patients with malignant pleural mesothelioma and non-small cell lung cancer.

Cantini, L., Pecci, F., Hurkmans, D. P., Copparoni, C., Aerts, S., Belderbos, R. A., Cornelissen, R., Dumoulin, D. P., Fiordoliva, I., Rinaldi, S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.15_suppl.3074 · Cited by 6 · see citing works

Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E

McManus, D., Novaira, H. J., Hamers, A. A. J., & Pillai, A. B. (2019) · Journal of Visualized Experiments · doi:10.3791/59821-v · Cited by 2 · see citing works

Lactate and lactylation in cancer

Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 524 · see citing works

Lactate: A key regulator of the immune response

Llibre, A., Kucuk, S., Gope, A., Certo, M., & Mauro, C. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.008 · Cited by 297 · see citing works

Dendritic cell maturation in cancer

Moon, C. Y., Belabed, M., Park, M. D., Mattiuz, R., Puleston, D. J., & Mérad, M. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-024-00787-3 · Cited by 186 · see citing works

Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives

Gu, X.-Y., Yang, J., Lai, R., Zhou, Z., Tang, D., Hu, L., & Zhao, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563303 · Cited by 162 · see citing works

Striking a balance: new perspectives on homeostatic dendritic cell maturation

Bosteels, V., & Janssens, S. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01079-5 · Cited by 81 · see citing works

Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy

Lv, Y., Li, Z., Liu, S., Zhou, Z., Jinling, S., Ba, Y., Weng, S., Zuo, A., Xu, H. W., Luo, P., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02407-6 · Cited by 83 · see citing works

Stemness in solid malignancies: coping with immune attack

Agudo, J., & Miao, Y. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00760-0 · Cited by 54 · see citing works

Lactate and lactylation in cancer: drivers of immune suppression and microenvironmental reprogramming

Ji, X., & Xia, L. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00719-3 · Cited by 47 · see citing works

Pericancerous cross-presentation to cytotoxic T lymphocytes impairs immunotherapeutic efficacy in hepatocellular carcinoma

Huang, C.-X., Lao, X., Wang, X., Ren, Y.-Z., Lu, Y., Shi, W., Wang, Y., Wu, C.-Y., Xu, L., Chen, M.-S., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.10.012 · Cited by 45 · see citing works

Acid affairs in anti-tumour immunity

Cappellesso, F., Mazzone, M., & Virga, F. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03520-0 · Cited by 42 · see citing works

Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis

Martin, O. P., Wallace, M. S., Oetheimer, C., Patel, H. B., Butler, E. C., Wong, L. P., Huang, P., Elbaz, J., Costentin, C., Salloum, S., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02255-y · Cited by 45 · see citing works

Lactylation: The metabolic accomplice shaping cancer's response to radiotherapy and immunotherapy

Yu, D., Zhong, Q., Wang, Y., Yin, C., Bai, M., Zhu, J. Y., Chen, J., Li, H., & Hong, W. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102670 · Cited by 36 · see citing works

Targeting tumor metabolism to augment CD8+ T cell anti-tumor immunity

Liu, H., Yang, W., & Jiang, J. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101150 · Cited by 36 · see citing works

Immunometabolic characteristics of Dendritic Cells and its significant modulation by mitochondria-associated signaling in the tumor microenvironment influence cancer progression

Ghosh, S., Dutta, R., Ghatak, D., Goswami, D., & De, R. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150268 · Cited by 35 · see citing works

Lactate at the crossroads of tumor metabolism and immune escape: a new frontier in cancer therapy

Dong, Z., Yuan, Z., Jin, T., Gao, C., Wang, X., & Xu, F. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07272-x · Cited by 34 · see citing works

The Role of Lactate in Immune Regulation: A Metabolic Rheostat via Transporters, Receptors, and Epigenetic Modifiers

Choi, E. J., Jang, Y. Y., Choi, E. J., & Oh, C. J. (2025) · Cells · doi:10.3390/cells14141096 · Cited by 35 · see citing works

Ferroptosis-induced SUMO2 lactylation counteracts ferroptosis by enhancing ACSL4 degradation in lung adenocarcinoma

Shan, G., Bian, Y., Sui, Q., Liang, J., Ren, S., Pan, B., Shi, H., Zheng, Z., Zeng, D., Zhu, J., et al. (2025) · Cell Discovery · doi:10.1038/s41421-025-00829-6 · Cited by 32 · see citing works

The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma

Gobbini, É., Hubert, M., Doffin, A., Eberhardt, A., Hermet, L., Li, D., Duplouye, P., Barrin, S., Berthet, J., Benboubker, V., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0421 · Cited by 31 · see citing works

Farnesyl pyrophosphate potentiates dendritic cell migration in autoimmunity through mitochondrial remodelling

Zhang, X., Chen, Y., Sun, G., Fei, Y., Zhu, H., Liu, Y., Dan, J., Li, C., Cao, X., & Liu, J. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01149-x · Cited by 29 · see citing works

The Application of Dendritic Cells Vaccines in Tumor Therapy and Their Combination with Biomimetic Nanoparticles

Zhu, T., Li, Y., Wang, Y., & Li, D. (2025) · Vaccines · doi:10.3390/vaccines13040337 · Cited by 29 · see citing works

Lactate and lactylation: molecular insights into histone and non-histone lactylation in tumor progression, tumor immune microenvironment, and therapeutic strategies

Xiao, S., Zhang, S., Sun, K., Huang, Q., Li, Q., & Hu, C. (2025) · Biomarker Research · doi:10.1186/s40364-025-00849-0 · Cited by 31 · see citing works

Influence of lactate in resistance to anti‑PD‑1/PD‑L1 therapy: Mechanisms and clinical applications (Review)

Zeng, Y., Huang, Y., Tan, Q., Peng, L., Wang, J., Tong, F., & Dong, X. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13413 · Cited by 27 · see citing works

Dendritic cells instruct T cell anti-tumor immunity and immunotherapy response

Xiao, Z., Wang, J., Yang, J., Guo, F., Zhang, L., & Zhang, L. (2025) · The Innovation Medicine · doi:10.59717/j.xinn-med.2025.100128 · Cited by 26 · see citing works

Lactate in skin homeostasis: metabolism, skin barrier, and immunomodulation

Ruan, D., Hu, T., Yang, X., Mo, X., & Ju, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1510559 · Cited by 23 · see citing works

Engineering Red Blood Cells for Amplified Tumor Dual‐Gas Transfusion Therapy

Li, T., Ouyang, M., Wang, W., Chen, S., Wang, C., Lai, J., Weng, P., Li, Z., Wang, Y., & Zhou, D. (2025) · Advanced Materials · doi:10.1002/adma.202503206 · Cited by 22 · see citing works

Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy

Jiang, C., Tang, M., Su, Y., Xie, J., Shang, Q., Guo, M., An, X., Lin, L., Wang, R., Huang, Q., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.04.002 · Cited by 21 · see citing works

Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy

Wei, J., Li, D., Long, H., & Han, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1562797 · Cited by 23 · see citing works

Phospholipid metabolism in innate immunity and inflammation: from basic to clinic

Liu, J., Chen, Y., & O'Neill, L. A. J. (2025) · Immunity & Inflammation · doi:10.1007/s44466-025-00001-5 · Cited by 20 · see citing works

Research progress on the regulatory role of lactate and lactylation in tumor microenvironment

Gao, C., Li, J., & Shan, B. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189339 · Cited by 19 · see citing works

Lactylation in Tumor Immune Escape and Immunotherapy: Multifaceted Functions and Therapeutic Strategies

Li, Q., Zhao, R., Shen, Y., Guo, D., Deng, L., Cai, R., Shen, Z., Xie, Z., Hang, N., Fu, S., et al. (2025) · Research · doi:10.34133/research.0793 · Cited by 19 · see citing works

Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways

Rennen, S., Bosteels, V., Nolf, C. D., Maréchal, S., Vetters, J., Lil, K. V., Webb, G. R., Swinnen, J., Velde, E. V. D., Fayazpour, F., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116150 · Cited by 20 · see citing works

Lactate metabolic checkpoint in immuno-oncology: mechanisms and therapeutic implications

Wang, Z., Gu, Z., Mo, W., & Zhang, H. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218038 · Cited by 19 · see citing works

Immunocyte lipid metabolic reprogramming: a novel pathway for targeted intervention in autoimmune diseases

Cui, Y.-Y., Feng, Z.-D., Zhao, Q.-H., Dai, H., Zheng, Y., Rui, H.-L., & Liu, B.-L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1713148 · Cited by 17 · see citing works

Lipid metabolism reprogramming shapes the immune landscape in the tumor microenvironment

Du, Y., Cai, Z.-R., Duan, X.-T., Li, X., Yue, T., Tian, T., Li, J.-J., & Ju, H. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01411-0 · Cited by 24 · see citing works

Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances

Fang, C., Zhou, S., Yu, K., Zhang, L., Lian, W., Tie, X., Chen, S., Dai, J., Li, Q. H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02672-x · Cited by 22 · see citing works

Bridging the gap: ferroptosis of immune cells in the tumor microenvironment

Wang, W., Li, H., Liang, S., Hu, Y., Ding, J., Wu, X., & Hua, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1648432 · Cited by 18 · see citing works

The LDH‐H3K18La‐Nur77 Axis Potentiates Immune Escape in Small Cell Lung Cancer

Shang, X., Cheng, B., Zhang, C., Zhao, C., Wang, R., Zhang, X., Jiang, D., Zhang, X., Ma, X., Mao, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202413608 · Cited by 17 · see citing works

Lactylation in cancer: mechanistic insights, tumor microenvironment, and therapeutic horizons

Yang, Q., Yang, Z., & Zhao, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1697008 · Cited by 17 · see citing works

Spatiotemporal Heterogeneity of Tumor Glucose Metabolism Reprogramming: From Single-Cell Mechanisms to Precision Interventions

Chai, X., Tao, Q., & Li, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146901 · Cited by 18 · see citing works

Engineered T cells stimulate dendritic cell recruitment and antigen spreading for potent anti-tumor immunity

Xiao, Z., Wang, J., He, S., Wang, L., Yang, J., Li, W. H., Ma, K., Zhou, Y., Liu, X., Wang, S., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102307 · Cited by 15 · see citing works

Biohybrid nanorobots induce lactate isomer conversion to reverse the immune environment and promote tumor therapy

Fan, Y., Ye, J., Niu, G., She, Y., Li, R., Shi, J., Yang, Y., Wang, L., Kang, Y., & Ji, X. (2025) · Science Advances · doi:10.1126/sciadv.adz8419 · Cited by 15 · see citing works

Lactate signaling and immune suppression in tumors: mechanisms and therapeutic implications

Wang, X., Xiong, D., Cui, S., Duan, B., Ding, G., Huang, Y., & Wang, Q. (2026) · Cellular Oncology · doi:10.1007/s13402-026-01186-6 · Cited by 16 · see citing works

Lactate and lactylation in liver diseases: energy metabolism, inflammatory immunity and tumor microenvironment

Cheng, S., Xiao, X., Wang, D., Wang, X., & Yang, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1581582 · Cited by 14 · see citing works

An Engineered Probiotic Consortium Based on Quorum‐Sensing for Colorectal Cancer Immunotherapy

Guo, Y., Gao, M., Wang, L., Yuan, H., Yin, J., Wu, J., Gao, X., Zhu, Z., Zhang, Y., Wang, Z., et al. (2025) · Advanced Science · doi:10.1002/advs.202512744 · Cited by 14 · see citing works

Microbial metabolites in tumor epigenetic regulation

Zhang, W., Zhang, H., Liao, Y., Jiang, S., Zhang, H., Huang, C., Song, Z., Zhao, R., Lü, P., Kang, X., et al. (2026) · iMeta · doi:10.1002/imt2.70115 · Cited by 16 · see citing works

HBV and host metabolic crosstalk: Reprogramming pathways for viral replication and pathogenesis

Yan, Y., Wei, Z., Zheng, M., Lu, M., & Wang, X. (2025) · Virologica Sinica · doi:10.1016/j.virs.2025.09.008 · Cited by 12 · see citing works

Dendritic cell vaccines: Current research progress, challenges, and opportunities

Zhang, S., Mo, S., Huang, W., Zhong, D., Yang, X., Xie, S., Liu, A., Mo, F., Huang, X., Liu, H., et al. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101913 · Cited by 15 · see citing works

Engineered Bacteria-Nanoparticle Conjugate Reprograms Immunosuppressive Niche via Dendritic Cell-Centric Innate-Adaptive Immune Coupling

Wang, X., Shi, G., Zhu, X., Liu, Z., Liu, M., Wu, Z., He, Z., Li, K., Zhang, T., Liu, H., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c03960 · Cited by 12 · see citing works

Radiotherapy-induced alterations in tumor microenvironment: metabolism and immunity

Chen, J., Wang, S., Ding, Y., Duo, X., & Zheng, S. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1568634 · Cited by 11 · see citing works

Lactate-Mediated Epigenetic and Immunometabolic Reprogramming in Glioma: An Emerging Axis Linking Metabolism to Tumor Progression

Xie, X., Zhou, W., Ku, Y., Li, S., Yang, Y., Hao, X., & Chen, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13123041 · Cited by 11 · see citing works

Nanomedicine-mediated modulation of tumor metabolism for enhanced immunotherapy

Liu, Y., Sun, D., Li, W., Zhang, Z., Li, C., Che, X., & Zhang, S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114587 · Cited by 10 · see citing works

Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention

Tang, L., Peng, S., Zhuang, X., He, Y., Song, Y., Nie, H., Zheng, C., Pan, Z., Lam, A. K.-Y., He, M., et al. (2025) · MedComm – Oncology · doi:10.1002/mog2.70012 · Cited by 10 · see citing works

Targeting cholesterol metabolism: a promising therapy strategy for cancer

Dai, C.-L., Qiu, Z.-Y., Wang, A., Shen, Y. H., Zhang, L., & Luan, X. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01531-9 · Cited by 10 · see citing works

Tumor Microenvironment: Obstacles and Opportunities for T Cell–Based Tumor Immunotherapies

Hu, M., Zhao, Y., Zhang, N., Gong, F., Zhang, W., Dong, C., Dai, J., & Wang, J. (2025) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-24-0747 · Cited by 9 · see citing works

Unraveling the link between cholesterol and immune system in cancer: From biological mechanistic insights to clinical evidence. A narrative review

Pecci, F., Cognigni, V., Giudice, G. C., Paoloni, F., Cantini, L., Saini, K. S., Abushukair, H. M., Naqash, A. R., Cortellini, A., Mazzaschi, G., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104654 · Cited by 9 · see citing works

Host-related Determinants of Response to Immunotherapy in Non-small Cell Lung Cancer: The Interplay of Body Composition, Metabolism, Sex and Immune Regulation

Santo, V., Brunetti, L., Pecci, F., Peroni, M., Barnini, G., Paoloni, F., Buti, S., Tiseo, M., Ricciuti, B., Pinato, D. J., et al. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01718-7 · Cited by 10 · see citing works

Hypoxia-induced immunosuppression in uveal melanoma is mediated by CD63+ exosomes delivering lactate to reprogram immune cells

Li, D., Zheng, S., & Feng, Y. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1743009 · Cited by 8 · see citing works

Optical probes for bioimaging of tumor-infiltrating immune cells and their applications in cancer immunotherapy

Chen, X., Hu, C., Kim, H., Zhang, L., Zhang, Z., Liu, H., & Yoon, J. (2026) · Chemical Society Reviews · doi:10.1039/d5cs01412c · Cited by 8 · see citing works

MultiOmics analysis of metabolic dysregulation and immune features in breast cancer

Zhou, Z.-Y., Bai, N., Zheng, W., & Ni, S. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114376 · Cited by 7 · see citing works

A multifunctional biomimetic nanoplatform combined with immune checkpoint blockade for triple-negative breast cancer immunotherapy through inhibiting polarization of M2 macrophages

Zhou, Q., Jia, Z., Yang, M., Xu, Y. F., Gao, F., Wang, R., Gu, L., Liu, F., Zhang, S., Chen, W., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03663-w · Cited by 7 · see citing works

An Enzyme‐Like Catalyzed Nanosheets for Redox Stress Oscillation Therapy Against Bacterial Infections

Ge, M., Guo, Z., Zhang, Z., Lu, L., Ruan, Z., Shi, T., Chen, Y., Huang, J., Tan, C., & Lin, H. (2025) · Advanced Science · doi:10.1002/advs.202519334 · Cited by 7 · see citing works

Lactylation and tumor immune regulation: insights from recent studies

Li, C.-H., Jiang, X.-L., Yuan, Y.-X., & Wang, Q. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1699314 · Cited by 13 · see citing works

SREBP2 as a central player in cancer progression: potential for targeted therapeutics

Chen, R., Chen, T., Li, X., Yu, J., Lin, M., Wen, S., Zhang, M., Chen, J., Yi, B., Zhong, H., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1535691 · Cited by 6 · see citing works

CircCDYL promotes glycolysis to drive the progression of nasopharyngeal carcinoma

Yang, Y., Wang, Y., Qu, H., Wang, D., Ge, J., Wu, P., Yan, Q., Chen, P., Xiang, B., Zhou, M. L., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.09.053 · Cited by 6 · see citing works

The Role of Lactate Metabolism in Tumors

Tian, Z., Zhang, K., Sheng, S., Kan, C., Han, F., & Sun, X. (2025) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000001276 · Cited by 6 · see citing works

The Diverse Roles of Lipid Metabolism Reprogramming in Shaping the Tumor Immune Microenvironment

Lee, J., Cheu, J. W., & Wong, C. C. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-2568 · Cited by 4 · see citing works

The immunological interface: dendritic cells as key regulators in metabolic dysfunction‐associated steatotic liver disease

Klaimi, C., Kong, W. T., Blériot, C., & Haas, J. T. (2024) · FEBS Letters · doi:10.1002/1873-3468.15072 · Cited by 5 · see citing works

From Cell Death and Activation to Paralysis: Dysregulated Conventional Dendritic Cells in SIRS , Sepsis and Major Trauma Promote Immunosuppression

Ashayeripanah, M., Roquilly, A., & Villadangos, J. A. (2026) · Immunological Reviews · doi:10.1111/imr.70087 · Cited by 4 · see citing works

Exploring the metabolic mysteries: Mechanistic insights into lactylation-mediated regulation of autoimmune diseases

Kang, N., Wang, B., Li, Y., & Zhu, R. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104024 · Cited by 4 · see citing works

Current research status of the reverse Warburg effect in cancer-associated fibroblasts of solid tumors

Xiao, L., Na, J., Dang, F., Shao, J., Su, J., Zhong, L., & Zhao, Y. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116586 · Cited by 4 · see citing works

Cholesterol metabolism in immune cells: From mechanisms to therapeutic opportunities

Yin, M., Liang, T., Zhang, Y., Wang, G., Yang, W., & Xu, C. (2026) · Immunity · doi:10.1016/j.immuni.2026.05.007 · Cited by 4 · see citing works

CAR‐DC combined with CAR‐T therapy for relapsed/refractory acute myeloid leukaemia: Research progress and future perspectives

Zhang, R., Zhang, J., Zhang, H., & Zhao, M. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70536 · Cited by 4 · see citing works

Ex Vivo Traceability Platform for Phospholipoproteomic Formulations: Functional Evidence Without Clinical Exposure

Gutiérrez-Sandoval, R., Gutiérrez-Castro, F., Muñoz-Godoy, N., Rivadeneira, I., Lagos, A., Muñoz, Í., Iturra, J., Krakowiak, F., Peña-Vargas, C., Vidal, M., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13092101 · Cited by 3 · see citing works

Glycolytic diversity drives immune complexity in cancer

Wu, C.-Y., Huang, C.-X., Yuan, W., & Kuang, D. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.11.002 · Cited by 4 · see citing works

Progenitor CD8+ T cells and hyper-Treg crosstalk: a driver of immune checkpoint inhibitor resistance in esophageal squamous cell carcinoma

Huang, S., Yan, J., Liu, W., & Li, B. (2026) · APOPTOSIS · doi:10.1007/s10495-025-02256-0 · Cited by 3 · see citing works

Enhancing antitumour nanovaccine efficacy via integrated cholesterol modulation in situ

Deng, Z., Lu, L., Xu, T., Zhao, Z., Geng, Y., Liu, L., Yang, M., Zheng, Y., Sun, Y., Lovell, J. F., et al. (2026) · Nature Nanotechnology · doi:10.1038/s41565-026-02153-w · Cited by 3 · see citing works

Glucose metabolic reprogramming as a driver of immunosuppression in the tumour microenvironment

Wang, Y., Lu, Y., Zhou, J., & Yang, X. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70665 · Cited by 3 · see citing works

The lactylation axis: bridging metabolic reprogramming and immunosuppression in the tumor microenvironment

Tao, X., Liu, Y., Yu, P., Wu, W., Fu, Y., Lan, P., & Jin, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1743101 · Cited by 3 · see citing works

TRIM8 enhances chondrocyte ferroptosis by inhibiting YTHDF2-m6A mediated SREBF2 mRNA degradation to promote OA progression

Liu, R., Xiao, Y., Zhang, G., Han, P., Lin, Z., & Song, H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114441 · Cited by 3 · see citing works

Advances of nanomedicine targeting the interface of cholesterol metabolism and immune evasion

Wang, C., Chen, B., Wang, Y., Xie, B., Yu, P., Xu, X., Wang, R., Miao, L., Yan, X., Li, Y., et al. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.110921 · Cited by 2 · see citing works

Identification of a novel immature dendritic cell subset with potential pro-leukemic effects in leukemia microenvironment

Cui, X., Li, Y., Xie, W., Li, R., Zhang, D., Zhang, S., Ren, Q., Wang, L., & Zheng, G. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07851-2 · Cited by 2 · see citing works

Amino acid and cholesterol metabolism in innate immunity

Li, W., Jin, M., Li, H., Zhong, R., Lin, Z., Shen, M., & Wang, H. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.09.019 · Cited by 2 · see citing works

BNIP3 is a key driver of breast cancer progression and a novel glycolysis-regulating biomarker

Cao, L., Yu, M., Zhang, G., Xu, L., Shi, J., & Gao, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-27560-2 · Cited by 2 · see citing works

In situ generation of dendritic cell vaccines in 3D printing scaffolds for cancer post-surgical therapy

Chen, L., Xu, Y., Hu, X., Pan, Y., She, P., Chen, X. S., Peng, Q., Li, Q., & Rao, L. (2026) · National Science Review · doi:10.1093/nsr/nwag037 · Cited by 2 · see citing works

Reprogramming the Tumor Mechanical Microenvironment with Lactate Inhibition and Stimulator of Interferon Genes Activation to Potentiate Systematic Radio-Immunotherapy

Mao, Q., Cai, H., Chen, M., Xiao, A., Jiao, H., Jia, F., Ma, J., Fan, J., Liu, J., Zhang, K., et al. (2026) · ACS Nano · doi:10.1021/acsnano.5c16809 · Cited by 2 · see citing works

Lactate metabolic reprogramming and lactylation modification: molecular mechanisms reshaping the tumor immunosuppressive microenvironment

Yuan, Y., Gao, Y., Xue, J., Zhang, H., Liang, R., Huang, L., Wang, Z., Song, L., Qin, Y., & Ai, J. (2026) · Cell & Bioscience · doi:10.1186/s13578-026-01572-5 · Cited by 2 · see citing works

Lipid metabolism as a central driver of immune remodeling and therapeutic vulnerability in metastatic colorectal cancer

Shang, Y., Yang, Q., Zhang, R., Xu, W., EL-Aty, A. M. A., Gao, Y., & Wang, T. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02956-9 · Cited by 2 · see citing works

Metabolic reprogramming of myeloid cells in cancer: from lactate–NAMPT axis to AI-guided therapeutics

Lee, I.-G., & Jung, K. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01759-3 · Cited by 2 · see citing works

Dendritic cell diversity and dysfunction in cancer: implications for immunotherapy and therapeutic targeting

Wang, R., Chen, Y., & Fang, Y.-F. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01868-9 · Cited by 2 · see citing works

The Role of Lactate in Cancer Immunotherapy: Mechanisms and Applications

Fan, Y., Jia, H., & Zhang, W. (2025) · Current Cancer Drug Targets · doi:10.2174/0115680096373625250701095509 · Cited by 2 · see citing works

Tumor-derived Extracellular Vesicles Induce ER Stress to Drive Tolerogenic Dendritic Cell Development in the Tumor MicroenvironmentPreprint

Wang, X. F., Plebanek, M. P., Nguyen, Y., Bazaz, M. R., Sturdivant, M. S., Theivanthiran, B., & Hanks, B. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.10.705213 · Cited by 2 · see citing works

Mitochondrial ABHD11 inhibition drives sterol metabolism to modulate T-cell effector function

Jenkins, B. J., Jenkins, Y. R., Ponce-Garcia, F. M., Moscrop, C., Perry, I. A., Hitchings, M. D., Uribe, A. H., Bernuzzi, F., Eastham, S., Cronin, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65417-4 · Cited by 2 · see citing works

HDM and mannose as novel tolerogenic inducers for dendritic cells: mTOR/PPARγ-mediated attenuation of allergic asthma

Wang, F., Min, Z., Gao, J., Qian, Y., Jiang, Z., Gao, X., & Chen, Z. H. (2025) · European journal of medical research · doi:10.1186/s40001-025-03547-7 · Cited by 1 · see citing works

CD8a antibody-functionalized biomimetic red blood cell membrane ectosomes delivering C646 reverse CD8⁺ T Cell exhaustion via H3K18la histone delactylation in gastric cardia adenocarcinoma

Xiang, Z., Zhang, X., Liu, X., Lv, X., Hu, Y., Zhang, C., Zou, C., Wang, A., Zhang, B., Wang, W. W., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03957-z · Cited by 1 · see citing works

Research progress on immune tolerance mechanisms in liver metastatic tumors and the “Liver-metastasis-oriented shared-mechanism therapeutic strategy” approach

Zhang, Q., Wang, W., Yu, H., Wang, F., Chen, X., Liang, Z., & Lu, Y. (2026) · Medical Review · doi:10.1515/mr-2025-0077 · Cited by 1 · see citing works

Phagocytosis of necroptotic cells optimizes type 1 conventional dendritic cells for induction of a cytotoxic T-cell response

Staal, M. D., Wang, Z., Bosma, D. M. T., Busselaar, J., Schrama, E., de Vries, E., Xiao, Y., & Borst, J. G. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01689-7 · Cited by 1 · see citing works

Molecular Targets for Cancer Immunotherapy: Focusing on (Immune and Tumor) Cell-Derived Metabolites

Quintans, R. D. T., de Freitas, Â. A., de Souza, M. M., Dias-Lopes, G., & Silva, R. C. M. C. (2026) · Applied Sciences · doi:10.3390/app16052461 · Cited by 1 · see citing works

Metronomic Chemotherapy Induces Metabolic Reprogramming in Cancer Cells That Modulates Mature Regulatory Dendritic Cell Function to Stimulate Antitumor Immunity

Deng, Z., Zhang, C., Wei, H., Hu, Z., Hua, G., Li, Z., Wu, J., He, T., Wang, Y., CAI, Y., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-3669 · Cited by 1 · see citing works

ATAD2 drives immunotherapy resistance by promoting lactic acid-mediated CD8+ T cell dysfunction in lung adenocarcinoma

Gao, W., Xu, J., Li, Y., Zhang, J., Ma, C., Chen, J., & Chen, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1800533 · Cited by 1 · see citing works

Protein lactylation: a metabolic signal driving cancer therapy resistance

D’Amico, S., Giovannini, S., Melino, G., Peschiaroli, A., & Bernassola, F. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03050-w · Cited by 1 · see citing works

A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progressionPreprint

Plebanek, M. P., Xue, Y., Nguyen, Y., DeVito, N. C., Wang, X., Holtzhausen, A., Beasley, G. M., Yarla, N. S., Thievanthiran, B., & Hanks, B. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.26.538456 · Cited by 4 · see citing works

Abstract 2892: A SREBF2-dependent genetic program drives a novel immunotolerant dendritic cell population that supports cancer progression

Plebanek, M. P., Xue, Y., Nguyen, Y., DeVito, N. C., Wang, X., Beasley, G. M., Yarla, N. S., Thievanthiran, B., & Hanks, B. A. (2023) · Cancer Research · doi:10.1158/1538-7445.am2023-2892

873 Investigating the role of NR4A1 in dendritic cell pro-tolerogenic function and its impact on anti-tumor immunity

Plebanek, M. P., Rezazadebazaz, M., Wang, X. F., Nguyen, Y., & Hanks, B. A. (2024) · Regular and Young Investigator Award Abstracts · doi:10.1136/jitc-2024-sitc2024.0873

657 Characterization and therapeutic targeting of a tumor-associated tolerogenic DC subpopulation driven by SREBP2 and the mevalonate metabolic pathway

Plebanek, M. P., DeVito, N. C., Liu, F., Theivanthiran, B., Beasley, G. M., & Hanks, B. A. (2021) · Regular and Young Investigator Award Abstracts · doi:10.1136/jitc-2021-sitc2021.657 · Cited by 1 · see citing works

Abstract 7428: Tumors induce a NR4A1 transcriptional program in dendritic cells leading to immune tolerance and cancer progression

Plebanek, M. P., Bazaz, M. R., Nguyen, Y., Theivanthiran, B., & Hanks, B. A. (2026) · Cancer Research · doi:10.1158/1538-7445.am2026-7428